CTMX Return on Tangible Equity | CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. (CTMX) Return on Tangible Equity

2026-06-30: Return Tang Equity -26.48%.
2026-03-31: Return Tang Equity -18.56%.
2025-12-31: Return Tang Equity -17.79%.
2025-09-30: Return Tang Equity 26.44%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-26.48%
2026-03-31	-18.56%
2025-12-31	-17.79%
2025-09-30	26.44%
2025-06-30	40.51%
2025-03-31	176.64%
2024-12-31	-1603.07%
2024-09-30	-55.27%
2024-06-30	-33.77%
2024-03-31	-49.62%
2023-12-31	1.16%
2023-09-30	19.23%
2023-06-30	48.67%
2023-03-31	79.89%
2022-12-31	113.41%
2022-09-30	180.86%
2022-06-30	252.59%
2022-03-31	417.70%
2021-12-31	4770.28%
2021-09-30	-65.73%
2021-06-30	-49.81%
2021-03-31	-42.13%
2020-12-31	332.51%
2020-09-30	-116.83%
2020-06-30	-110.57%
2020-03-31	-112.39%
2019-12-31	-209.28%
2019-09-30	-124.06%
2019-06-30	-99.58%
2019-03-31	-69.25%
2018-12-31	-65.85%
2018-09-30	-33.34%
2018-06-30	-99.77%
2018-03-31	-106.80%
2017-12-31	-64.00%
2017-09-30	-134.66%
2017-06-30	-125.50%
2017-03-31	-71.92%
2016-12-31	-77.72%
2016-09-30	-64.98%
2016-06-30	-54.38%
2016-03-31	-41.08%
2015-12-31	-28.67%
2015-09-30	26.80%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-17.79%
2024-12-31	-1603.07%
2023-12-31	1.16%
2022-12-31	113.41%
2021-12-31	4770.28%
2020-12-31	332.51%
2019-12-31	-209.28%
2018-12-31	-65.85%
2017-12-31	-64.00%
2016-12-31	-77.72%
2015-12-31	-28.67%
2014-12-31	38.13%
2013-12-31	34.20%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
Neurogene Inc. (NGNE)		$0.625B	-4.46
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B